Monday, 13 April 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 13 April 2026
News

Takeda snags former Sanofi market

Posted 13 April 2026 AM

Takeda has moved into a market formerly held by Sanofi, with the TGA’s approval of its dengue vaccine Qdenga.

Qdenga is a genetically modified vaccine that contains four live weakened strains of dengue virus, intended to stimulate immune responses. It is indicated for the prevention of dengue disease in individuals from four years of age.

To see the whole article, please login

Popular

Who's joined the TGA's review list?
$210K tit-for-tat Aussie Code fines
Meet industry's $50M-a-year Boss
New Medical Affairs leader named
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home